Geometric and dosimetric evaluation of the differences between rigid and deformable registration to assess interfraction motion during pelvic radiotherapy

Autor: Ingrid, White, Dualta, McQuaid, Helen, McNair, Alex, Dunlop, Steven, Court, Naomi, Hopkins, Karen, Thomas, David, Dearnaley, Shree, Bhide, Susan, Lalondrelle

Publikováno v: Physics and Imaging in Radiation Oncology, Vol 9, Iss, Pp 97-102 (2019)
Physics and Imaging in Radiation Oncology

Highlights • Target motion assessment using rigid and non-rigid strategies significantly differ. • Geometric changes are not accounted for in margins using rigid approximation. • Rectal volume is moderately correlated with anterior/posterior ta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f60391920c4a54de319c899a4b18a32b
http://www.sciencedirect.com/science/article/pii/S2405631618300678

Prospective quantitative quality assurance and deformation estimation of MRI-CT image registration in simulation of head and neck radiotherapy patients

Autor: Jack Phan, Amit Jethanandani, Kendall J. Kiser, Houda Bahig, Neamat Hegazy, Yao Ding, Gary Brandon Gunn, Y. Rostom, Renjie He, Sweet Ping Ng, M.A.M. Meheissen, David I. Rosenthal, Stephen Y. Lai, Clifton D. Fuller, Hesham Elhalawani, Steven J. Frank, Jihong Wang, Kristy K. Brock, Mona Kamal, Adam S. Garden, Joint Head, Abdallah S.R. Mohamed

Publikováno v: Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 18, Iss, Pp 120-127 (2019)

Highlights • MRI-CT deformable image registration was not superior to rigid registration. • Dice similarity coefficients were 0.65, 0.62, and 0.63 for deformable registrations. • Dice similarity coefficient was 0.63 for rigid registration. •

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59082a03edfae225ff793dc9d65fb577
https://pubmed.ncbi.nlm.nih.gov/31341987

Prospective quantitative quality assurance and deformation estimation of MRI-CT image registration in simulation of head and neck radiotherapy patients.

Autor: Kiser K; University of Texas, John P. and Kathrine G. McGovern Medical School, 6431 Fannin Street, Houston, TX 77030, USA.; UT Health School of Biomedical Informatics, 7000 Fannin Street, Suite 600, Houston, TX 77030, USA.; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Meheissen MAM; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, 17 Champilion Street, Alazarita, Alexandria, Egypt., Mohamed ASR; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, 17 Champilion Street, Alazarita, Alexandria, Egypt.; MD Anderson Cancer Center/UT Health Graduate School of Biomedical Sciences, 6767 Bertner Avenue, Houston, TX 77030, USA., Kamal M; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Ain Shams, Lofty El-Said Street, 1156 Cairo, Egypt., Ng SP; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Radiation Oncolog, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia., Elhalawani H; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Jethanandani A; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; College of Medicine, University of Tennessee Health Science Center, 910 Madison Avenue #1002, Memphis, TN 38103, USA., He R; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Ding Y; Department of Radiation Physics, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Rostom Y; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, 17 Champilion Street, Alazarita, Alexandria, Egypt., Hegazy N; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, 17 Champilion Street, Alazarita, Alexandria, Egypt., Bahig H; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Radiation Oncology, Centre Hospitalier de l'Universite de Montreal, 1051 Rue Sanguinet, Montreal, QC H2X 3E4, Canada., Garden A; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Lai S; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Phan J; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Gunn GB; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Rosenthal D; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Frank S; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Brock KK; Department of Radiation Physics, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Department of Imaging Physics, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Wang J; Department of Radiation Physics, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA., Fuller CD; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, The MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2019 Apr 24; Vol. 18, pp. 120-127. Date of Electronic Publication: 2019 Apr 24 (Print Publication: 2019).

The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer.

Autor: Esteyrie V; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Gleyzolle B; Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Lusque A; Biostatistics Unit, Institut Claudius Regaud-, Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, France., Graff P; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Modesto A; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Rives M; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Lapeyre M; Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Desrousseaux J; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Graulières E; Engineering and Medical Physics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Hangard G; Engineering and Medical Physics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Arnaud FX; Engineering and Medical Physics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Ferrand R; Engineering and Medical Physics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Delord JP; Clinical Trials Office , Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Poublanc M; Clinical Trials Office , Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Mounier M; Clinical Trials Office , Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole. Toulouse, France., Filleron T; Biostatistics Unit, Institut Claudius Regaud-, Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, France., Laprie A; Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2019 Mar 09; Vol. 16, pp. 34-39. Date of Electronic Publication: 2019 Mar 09 (Print Publication: 2019).